NAFDAC Newsroom
The list below provides information gathered from press releases and other public notices of The Agency
Highlights
-
Public Alert No. 36/2025 – WHO Alert on 3 Substandard (contaminated) oral liquid medicines identified in India
-
Public Alert No. 35/2025 – Substandard batches of Annmox (Amoxicillin suspensions 125mg/5ml) and Jawamox (Amoxicillin suspension 125mg/5ml) manufactured by Jawa International Ltd due to low Active Pharmaceutical Ingredient (API) content
-
Public Alert No. 34/2025 –Substandard Astamocil (Amoxicillin Suspension 125mg/5ml), Batch No. 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension), Batch Nos: 0503024 & 0501724, manufactured by Sam-Ace Ltd in Nigeria
-
Public Alert No. 033/2025 – Alert on the Sale of Counterfeit Cialis Tablet 20mg in Nigeria
-
Public Alert No. 032/2025 – Alert on the Discontinuation of the Production of Penicillin-Based Moiety by Miraflash
-
Public Alert No. 031/2025 – Alert on the Presence of an Unauthorized/ Unregistered Darzalex (Daratumumab) 1800mg/15ml vial SC Injection in Nigeria
News
- Press Announcements
- Speeches
- Events
- Approvals
- Warning Letters
- Notes to Industries
- Recalls & Alerts
- Testimony
Profile & Photos
Quick Links
- Approval of NAFDAC Regulated Products
- Freedom of Information
Events
- NAFDAC Meetings Conferences & Workshops
- Campus Tours
- Sensitization
- Content Current as of January 22, 2024
More Actions
